---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: "[[Cholinergic Blocking Drugs for Parkinson Disease]]"
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Antiparkinson]]"
SecondarySubClass: "[[Cholinergic Blocking Drugs (Anticholinergics)]]"
BrandName: Cogentin
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
 Parkinson disease, drug-induced [[EPS]] ([[EPS]])
0.5– 6 mg/ day orally Acute [[dystonia]]: 1– 2 mL IM or IV

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Dry [[Mouth]], blurred [[Vision]], dizziness, nausea, nervousness, skin rash, urinary retention, dysuria, tachycardia, muscle weakness, disorientation, confusion

### Interactions



 